Article
Spliceosome Inhibition in <i>SF3B1</i>-Mutated Uveal Melanoma
2022-09-23
Abstract excerpt
Treatment of uveal melanoma (UM) patients with metastatic disease is unfortunately limited. Twenty percent of UM harbor a mutation in splicing factor gene SF3B1 , suggesting that aberrant spliceosome functioning plays a vital role in tumorigenesis. Splicing inhibitors exploit the preferential sensitivity of spliceosome compromised leukemic cells to these compounds. We have studied the effect of splicing inhibitor...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8436ac1a-7ec2-5424-8a69-0d597071701c
- DOI
- 10.1101/2022.09.20.22280164
